Pancreatic islets engineered with a FasL protein induce systemic tolerance at the induction phase that evolves into long‐term graft‐localized immune privilege
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pancreatic islets engineered with a FasL protein induce systemic tolerance at the induction phase that evolves into long‐term graft‐localized immune privilege
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF TRANSPLANTATION
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-12-18
DOI
10.1111/ajt.15747
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Local immunomodulation with Fas ligand-engineered biomaterials achieves allogeneic islet graft acceptance
- (2018) Devon M. Headen et al. NATURE MATERIALS
- Localized immune tolerance from FasL-functionalized PLG scaffolds
- (2018) Michael Skoumal et al. BIOMATERIALS
- Phase 3 Trial of Transplantation of Human Islets in Type 1 Diabetes Complicated by Severe Hypoglycemia
- (2016) Bernhard J. Hering et al. DIABETES CARE
- Real-time immune cell interactions in target tissue during autoimmune-induced damage and graft tolerance
- (2014) Jason Miska et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Development of Either Split Tolerance or Robust Tolerance along with Humoral Tolerance to Donor and Third-Party Alloantigens in Nonmyeloablative Mixed Chimeras
- (2014) W. F. N. Chan et al. JOURNAL OF IMMUNOLOGY
- Induction of Tolerance to Cardiac Allografts Using Donor Splenocytes Engineered to Display on Their Surface an Exogenous Fas Ligand Protein
- (2014) E. S. Yolcu et al. JOURNAL OF IMMUNOLOGY
- Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors
- (2014) Gregory T Motz et al. NATURE MEDICINE
- Primary Vascularization of Allografts Governs Their Immunogenicity and Susceptibility to Tolerogenesis
- (2013) C. D. Kant et al. JOURNAL OF IMMUNOLOGY
- Intragraft CD11b+IDO+Cells Mediate Cardiac Allograft Tolerance by ECDI-Fixed Donor Splenocyte Infusions
- (2012) G. Chen et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Pancreatic Islets Engineered with SA-FasL Protein Establish Robust Localized Tolerance by Inducing Regulatory T Cells in Mice
- (2011) E. S. Yolcu et al. JOURNAL OF IMMUNOLOGY
- Tumor cells engineered to codisplay on their surface 4-1BBL and LIGHT costimulatory proteins as a novel vaccine approach for cancer immunotherapy
- (2010) R K Sharma et al. CANCER GENE THERAPY
- In vivo tracking of 'color-coded' effector, natural and induced regulatory T cells in the allograft response
- (2010) Zhigang Fan et al. NATURE MEDICINE
- Regulatory T Cells Sequentially Migrate from Inflamed Tissues to Draining Lymph Nodes to Suppress the Alloimmune Response
- (2009) Nan Zhang et al. IMMUNITY
- The mTOR Kinase Differentially Regulates Effector and Regulatory T Cell Lineage Commitment
- (2009) Greg M. Delgoffe et al. IMMUNITY
- Membrane-bound Fas ligand only is essential for Fas-induced apoptosis
- (2009) Lorraine A. O’ Reilly et al. NATURE
- CD3-specific antibody–induced immune tolerance involves transforming growth factor-β from phagocytes digesting apoptotic T cells
- (2008) Sylvain Perruche et al. NATURE MEDICINE
- ECDI-fixed allogeneic splenocytes induce donor-specific tolerance for long-term survival of islet transplants via two distinct mechanisms
- (2008) X. Luo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started